Physician profile
Lynn D Johnson
NPI 1740296763
$2,528.69
in general payments reported to CMS, 2019-2025
16 companies · $326 in 2025
The $326 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $379 · 2020: $161 · 2021: $315 · 2022: $14.24 · 2023: $541 · 2024: $793 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,658.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $393.16 | 2024 | Miebo, Infuse Multifocal, Xiidra |
| Alcon Vision LLC | $338.22 | 2020-2025 | Tryptyr |
| Johnson & Johnson Vision Care, INC. | $324.40 | 2022-2024 | Acuvue |
| Glaukos Corporation | $188.28 | 2019-2024 | Idose |
| Astellas Pharma US INC | $150.00 | 2023 | |
| Eyevance Pharmaceuticals LLC | $148.23 | 2021 | |
| Apellis Pharmaceuticals, INC. | $125.00 | 2025 | Syfovre |
| Amgen INC. | $125.00 | 2024 | Tepezza |
| Coopervision INC. | $124.68 | 2024 | Myday Contact Lens |
| Abbvie INC. | $121.70 | 2023 | |
| Aerie Pharmaceuticals, INC. | $113.27 | 2019 | |
| Novartis Pharmaceuticals Corporation | $97.54 | 2019 | |
| Optovue, INC. | $94.45 | 2019 | |
| Rxsight INC | $88.24 | 2023 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Lkc Technologies, INC. | $75.56 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynn Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.